<DOC>
	<DOCNO>NCT00798902</DOCNO>
	<brief_summary>This pilot study evaulate safety prelimary effectiveness Prefix compare autogenous bone spinal fusion procedure skeletally mature subject degenerative disc disease ( DDD ) one level L2-S1 .</brief_summary>
	<brief_title>Pilot Study Assess Safety/Preliminary Effectiveness Prefix Subjects With Degenerative Disc Disease ( DDD ) Undergoing Spine Fusion Surgery</brief_title>
	<detailed_description />
	<mesh_term>Spondylolisthesis</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>Documented diagnosis DDD require single level fusion ( L2S1 ) Grade I Spondylolisthesis Have preoperative screening qualify VAS ODI score Be skeletally mature male nonpregnant , nonlactating female , age 18 70 inclusive Have sufficiently responsive least 6 month nonoperative treatment prior study enrollment Are female subject pregnant nursing , woman plan become pregnant first year ( 12 month ) follow surgery A history previous surgery lumbar spine without attempted fusion Grade II great spondylolisthesis More 0 degree kyphosis operate disc space Evidence scoliosis lumbar region 10 degree Collapsed disc space bridge osteophytes A systemic local infection site surgery An acute fracture spine time enrollment study An active history systemic malignancy A medical condition , serious intercurrent illness , extenuate circumstance , opinion Investigator , would preclude participation study A known hypersensitivity component product know titanium allergy know allergy polyetheretherketone ( PEEK ) A history autoimmune disease , , systemic lupus erythematosus , Addison 's disease , Crohn 's disease , rheumatoid arthritis A history severe allergy anaphylaxis , history hypersensitivity protein pharmaceutical , previous exposure protein pharmaceutical Are receive treatment ( surgery ) drug ( e.g. , steroid , methotrexate , etc . ) interfere bone metabolism treat bone growth stimulator A medical condition require radiation , chemotherapy immunosuppression , medical condition require systemic corticosteroid Are cover workman 's compensation insurance prisoner Are transient treat last 6 month enrollment alcohol and/or drug abuse insubject substance abuse program Have participate clinical study within 3 month enrollment Have body mass index ( BMI ) great 35 Use tobacco product ( also include , e.g . nicotine patch nicotine gum ) , smoke cigarette within 6 week precede enrollment Known require additional surgery lumbar spinal region within next 6 month Have symptomatic multilevel degenerative disease require possible instrument fusion one vertebral level Have previously treat , expose , therapeutic level Bone Morphogenetic Proteins ( BMPs ) , i.e. , synthetic recombinant Have document medical history radiographic evidence metabolic bone disease ( e.g. , osteoporosis osteopenia ) condition would negatively impact bone heal process ( e.g . history Paget 's disease , osteomalacia , osteodystrophy ) preclude subject receive pedicle screw fixation Are involve planning engage litigation relate back and/or leg pain Require chronic SQ IV heparin therapy Have Osteoporosis Risk Assessment Instrument ( ORAI ) score &gt; 9 point , , require qualify DEXA scan T score</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>DDD</keyword>
	<keyword>Spondylolisthesis</keyword>
	<keyword>Spine Fusion</keyword>
	<keyword>Lumbar Spine</keyword>
	<keyword>Bone Graft</keyword>
</DOC>